RE: Bouncebackability23 Sep 2020 16:07
@lp
depends on your expectations
odx rose £42M MMcap on the Rumour of a single one off test order of £3M
one lab in India would give an annual income of £5M if you play with the maths that is a MMcap increase of £70M for GDR from ONE lab want to do the rest of the maths? try doing that kind of increase with NCYT. Not in my view a bad start for Indian sales. factor in Beckman and US dod order of 5M coming in this quarter and potential POC development and potential NHS up take of antibiotic hearloss kit and potential un countries uptake of Hepc POC test. well i think we have some good value there.